Association between the Adherence to the International Guidelines for Cancer Prevention and Mammographic Density

• Adela Castelló ,

  * E-mail: acastello@isciii.es

  Affiliations Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain

  ⨯
• Leandro Prieto,

  Affiliation Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain

  ⨯
• María Ederra,

  Affiliation Navarre Breast Cancer Screening Program, Public Health Institute, Pamplona, Spain

  ⨯
• Dolores Salas-Trejo,

  Affiliation Valencian Breast Cancer Screening Program, General Directorate of Public Health, Valencia, Spain

  ⨯
• Carmen Vidal,

  Affiliation Cancer Prevention and Control Unit, Catalonian Institute of Oncology (ICO. Barcelona, Spain

  ⨯
• Carmen Sánchez-Contador,

  Affiliation Balearic Islands Breast Cancer Screening Program, Regional Authority for Health & Consumer Affairs, Palma de Mallorca, Islas Baleares

  ⨯
• Carmen Santamariña,

  Affiliation Galician Breast Cancer Screening Program, Galician Regional Health Authority, A Coruña, Spain

  ⨯
• Carmen Pedraz,

  Affiliation Castile-León Breast Cancer Screening Program, General Directorate of Public Health, Burgos, Spain

  ⨯
• Pilar Moreo,

  Affiliation Aragón Breast Cancer Screening Program, Aragon Health Service, Zaragoza, Spain

  ⨯
• Nuria Aragonés,

  Affiliations Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain

  ⨯
• Beatriz Pérez-Gómez,

  Affiliations Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain

  ⨯
• Virginia Lope,

  Affiliations Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain

  ⨯
• Jesús Vioque,

  Affiliations Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Universidad Miguel Hernandez, Sant Joan D'Alacant, Spain

  ⨯
• Marina Pollán,

  Affiliations Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain, Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Madrid, Spain

  ⨯
• DDM-Spain research group

  ¶Membership of the DDM-Spain research group is provided in the acknowledgments section.

  ⨯